MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Cancellation Rate Risks: SueWallSt

Time-Sensitive: Allegations Focus on Misrepresentations About Backlog Cancellation Behavior NEW YORK, April 30, 2026 /PRNewswire/ -- SueWallSt alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) that a pending securities class action has been filed on behalf of shareholders who purchased securities between April 22, 2025 and February 9, 2026. Class Period: April 22, 2025 through February 9, 2026 Check if you can recover your investment losses or contact Joseph E.

PRNewsWire • 3 hours ago

MEDP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 30, 2026 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

PRNewsWire • 2 hours ago

Portnoy Law Firm Announces Class Action on Behalf of Medpace Holdings, Inc. Investors

LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace” or the "Company") (NASDAQ: MEDP) investors of a class action on behalf of investors that bought securities between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). Medpace investors have until June 8, 2026 to file a lead plaintiff motion.

GlobeNewsWire • 3 hours ago

Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, April 29, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”).

GlobeNewsWire • a day ago

MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Growth Outlook: Levi & Korsinsky

From Optimism to Disillusionment: How Investor Sentiment Shifted on MEDP NEW YORK, April 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP provides context on the evolution of investor sentiment surrounding Medpace Holdings Inc. (NASDAQ: MEDP) and a pending securities class action covering purchases between April 22, 2025 and February 9, 2026. Find out if you can recover your MEDP investment losses  or contact Joseph E.

PRNewsWire • Apr 29, 2026

$MEDP Fraud: Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Medpace, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/medpace-class-action-lawsuit.

GlobeNewsWire • Apr 29, 2026

Robbins LLP Reminds MEDP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Medpace Holdings Inc.

SAN DIEGO, April 29, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.

PRNewsWire • 13 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - April 29, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Medpace securities between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period").

Newsfile Corp • a day ago

ROSEN, A LEADING LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MEDP

New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased Medpace common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp • 18 hours ago

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before June 5, 2026.

GlobeNewsWire • Apr 28, 2026